LYSOGENE
A former clinical-stage biotech that developed gene therapies for rare CNS diseases.
LYS | PA
Overview
Corporate Details
- ISIN(s):
- FR0013233475
- LEI:
- 969500T64RILK1RD0852
- Country:
- France
- Address:
- 18 RUE JACQUES DULUD, 92200 NEUILLY-SUR-SEINE
- Website:
- https://www.lysogene.com
Description
Lysogene was a clinical-stage biotechnology company that specialized in the research and development of gene therapies for rare, inherited neurodegenerative diseases affecting the central nervous system (CNS). The company's approach focused on delivering a functional copy of a deficient gene directly to the brain to address the root cause of the targeted disorder. Its pipeline included investigational treatments for lysosomal storage diseases such as Sanfilippo syndrome type A (MPS IIIA) and GM1 gangliosidosis. Following clinical and financial challenges, the company initiated judicial liquidation proceedings in 2023.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-05-26 17:32 |
Informations privilégiées / Autres communiqués
|
French | 84.9 KB | ||
| 2023-05-26 17:32 |
Inside Information / Other news releases
|
English | 83.2 KB | ||
| 2023-05-26 10:00 |
Informations privilégiées / Autres communiqués
|
French | 85.6 KB | ||
| 2023-05-26 10:00 |
Inside Information / Other news releases
|
English | 83.5 KB | ||
| 2023-05-15 18:00 |
Inside Information / Other news releases
|
English | 83.5 KB | ||
| 2023-05-15 18:00 |
Informations privilégiées / Autres communiqués
|
French | 85.6 KB | ||
| 2023-04-29 18:00 |
Inside Information / News release on accounts, results
|
English | 82.9 KB | ||
| 2023-04-29 18:00 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 85.1 KB | ||
| 2023-04-14 18:00 |
Inside Information / Other news releases
|
English | 83.2 KB | ||
| 2023-04-14 18:00 |
Informations privilégiées / Autres communiqués
|
French | 85.4 KB | ||
| 2023-03-24 20:00 |
Informations privilégiées / Autres communiqués
|
French | 95.8 KB | ||
| 2023-03-24 20:00 |
Inside Information / Other news releases
|
English | 93.5 KB | ||
| 2023-02-16 18:00 |
Inside Information / Other news releases
|
English | 107.8 KB | ||
| 2023-02-16 18:00 |
Informations privilégiées / Autres communiqués
|
French | 110.2 KB | ||
| 2023-02-03 18:00 |
Informations privilégiées / Autres communiqués
|
French | 91.3 KB |
Automate Your Workflow. Get a real-time feed of all LYSOGENE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LYSOGENE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LYSOGENE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
